ClinicalTrials.Veeva

Menu

Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 (STOP-COVID)

Mass General Brigham logo

Mass General Brigham

Status

Completed

Conditions

Coronavirus Infection

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

NCT04343898
2007P000003

Details and patient eligibility

About

Multicenter observational/registry study of the clinical features and outcomes of critically ill patients with COVID-19.

Full description

The goals of this project are to determine the independent risk factors for hospital mortality and acute organ injury, and to identify treatment strategies associated with improved survival. Additionally, we will assess outcomes according to differences in geographic and institutional parameters.

Enrollment

5,154 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria (each of the following):

  1. Adults (aged ≥18 years)
  2. Laboratory-confirmed diagnosis of COVID-19
  3. Hospitalized in the ICU for illness related to COVID-19

Exclusion Criteria:

-None

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems